LakeShore Biopharma Co., Ltd. (LSBCF) › Cash & EquivalentsLakeShore Biopharma Co., Ltd. (LSBCF) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.Fiscal YearCash & EquivalentsChange YoY2023370.40M CNY—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share